The effect of erythropoietin on gentamicin-induced auditory hair cell loss

Laryngoscope

Volumn 116, Issue 2, 2006, Pages 312-316

  Monge, Arianne ^a,b   Nagy, Ivana ^a   Bonabi, Sharouz ^a   Schmid, Stephan ^a   Gassmann, Max ^b   Bodmer, Daniel ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Apoptosis; Erythropoietin receptor; Inner ear; Organ of Corti; Protection

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GENTAMICIN; MESSENGER RNA; ANTIINFECTIVE AGENT; NEUROPROTECTIVE AGENT; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL LOSS; CONTROLLED STUDY; CORTI ORGAN; HAIR CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPIRAL GANGLION; ANIMAL; APOPTOSIS; CELL CULTURE; DISEASE MODEL; DRUG EFFECT; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; APOPTOSIS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; GENTAMICINS; HAIR CELLS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ERYTHROPOIETIN;

EID: 33645777603     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000199400.08550.3f     Document Type: Article

References (15)

1. Huang T, Cheng AG, Stupak H, et al. Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. IntJ Dev Neurosci 2000;18:259-270.
2. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992;72:449-489.
3. Caye-Thomasen P, Wagner N, Lidegaard Frederiksen B, Asal K, Thomsen J. Erythropoietin and erythropoietin receptor expression in the guinea pig inner ear. Hear Res 2005;203:21-27.
4. Gassmann M, Heinicke K, Soliz J et al. Non-erythroid functions of erythropoietin. Adv Exp Med Biol 2003;543:323-330.
5. Lewis LD. Preclinical and clinical studies: a preview of potential future applications of erythropoietic agents. Semin Hematol 2004;41:17-25.
6. Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004;11:37-44.
7. Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002;8:495-505.
8. Corbacella E, Lanzoni I, Ding D, Prevati M, Salvi R. Minocycline attenuates gentamicin induced hair cell loss in neonatal cochlear cultures. Hear Res 2004;197:11-18.
9. Chong ZZ, Kang JQ, Maiese K. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br J Pharmacol 2003;138:1107-1118.
10. Nagy I, Bodmer M, Brors D, Bodmer D. Early gene expression in the organ of Corti exposed to gentamicin. Hear Res 2004;195:1-8.
11. Nagy I, Bodmer M, Schmid S, Bodmer D. Promyelocytic leukemia zinc finger protein localizes to the cochlear outer hair cells and interacts with prestin, the outer hair cell motor protein. Hear Res 2005;204:216-222.
12. Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 1999;55:808-820.
13. Juul SE, Yachnis AT, Rojiani AM, Christensen RD. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol 1999;2:148-158.
14. Shaheen FA, Mansuri NA al-ShaikhAM, et al. Reversible uremic deafness: is it correlated with the degree of anemia? Ann Otol Rhinol Laryngol 1997;106:391-393.
15. Markowski J, Gierek T, Wiecek A, Klimek D, Chudek J. Assessment of hearing organ ability in high-frequency auditory in patients suffering from chronic renal failure treated by haemodialysis and human recombinant erythropoietin (rhEPO). Otolaryngol Pol 2002;56:589-596.